Haptoglobin phenotype and diabetic nephropathy.

Area of Science:

• Genetics and Medicine
• Endocrinology
• Nephrology

Background:

• Diabetic nephropathy is a leading cause of kidney failure in diabetic patients.
• Genetic factors play a role in the susceptibility to diabetic nephropathy.
• Haptoglobin (HP) is a protein involved in hemoglobin binding and has been investigated for its role in various diseases.

Purpose of the Study:

• To investigate the association between the haptoglobin 2 allele and the risk of developing diabetic nephropathy.
• To determine if the presence and number of haptoglobin 2 alleles correlate with the incidence of microalbuminuria and macroalbuminuria in diabetic individuals.

Main Methods:

• A study was conducted on 110 normotensive patients with Type I or Type II diabetes mellitus.
• Patients had diabetes duration exceeding 10 years (Type I) or 5 years (Type II).
• Haptoglobin typing was performed using gel electrophoresis, and urinary protein excretion was measured to define microalbuminuria and macroalbuminuria.

Main Results:

• No subjects homozygous for the haptoglobin 1 allele (1-1) exhibited diabetic nephropathy.
• In contrast, 34% of subjects homozygous for the haptoglobin 2 allele (2-2) and 27% of heterozygous subjects (2-1) showed signs of diabetic nephropathy (p < 0.04).
• A graded risk was observed, with individuals having two haptoglobin 2 alleles showing a higher risk of macroalbuminuria (22%) compared to those with one (8%) or no haptoglobin 2 alleles (0%) (p < 0.03).

Conclusions:

• The haptoglobin phenotype, specifically the haptoglobin 2 allele, appears to be a significant susceptibility factor for diabetic nephropathy.
• A dose-dependent relationship exists between the number of haptoglobin 2 alleles and the risk of developing diabetic nephropathy in both Type I and Type II diabetes.
• These findings support the hypothesis that haptoglobin genotype is a major determinant in the development of diabetic kidney disease.